Axcell Biotechnologies' Acquisition

Axcell Biotechnologies was acquired by Imaxio on December 12, 2008.

Axcell Biotechnologies is a biopharma company that has developed Spirolept, a vaccine against human leptospirosis marketed in France. In April 2012, Axcell Biotechnologies was acquired by Imaxio. The…

Articles about Axcell Biotechnologies' Acquisition: